Showing results (2091-2100 of 2,155) with videos related to
Sort By:
Pageof 216
Journal of Biopharmaceutical Statistics|December 26, 2024
The effect of misclassification on sample size for one and two-sample tests with binary endpointsPéter Hársfalvi, Jenő ReiczigelJournal of Biopharmaceutical Statistics|January 20, 2025
Missing data in the eligibility criteria of synthetic controls from real-world dataLiang Li, Thomas Jemielita, Cong ChenJournal of Biopharmaceutical Statistics|March 13, 2025
Statistical considerations for using tolerance interval to set product specification for normally distributed attributeChang Chen, Yi Tsong, Xutong Zhao, et al.Journal of Biopharmaceutical Statistics|December 12, 2024
A multiple imputation approach in enhancing causal inference for overall survival in randomized controlled trials with crossoverRuochen Zhao, Junjing Lin, Jing Xu, et al.Journal of Biopharmaceutical Statistics|August 31, 2024
Optimum designs for clinical trials in personalized medicine when response variance depends on treatmentBelmiro P M Duarte, Anthony C AtkinsonJournal of Biopharmaceutical Statistics|November 25, 2024
Revolutionizing cardiovascular disease classification through machine learning and statistical methodsTapan Kumar Behera, Siddhartha Sathia, Sibarama Panigrahi, et al.Journal of Biopharmaceutical Statistics|November 6, 2024
An investigation to improve a nonlinear mixed-effects approach for EC50 estimation based on multi-donor dose-response dataWeiliang Qiu, Cheng Wenren, Els Pattyn, et al.Journal of Biopharmaceutical Statistics|November 4, 2024
Large-scale dependent multiple testing via higher-order hidden Markov modelsCanhui Li, Jiangzhou Wang, Pengfei WangJournal of Biopharmaceutical Statistics|August 11, 2024
Strategies for successful dose optimization in oncology drug development: a practical guideQiqi Deng, Lili Zhu, Brendan Weiss, et al.Journal of Biopharmaceutical Statistics|July 19, 2024
Leveraging pharmacokinetic parameters as covariate in Bayesian logistic regression model to optimize dose selection in early phase oncology trialXin Wei, Xiaosong Li, Ziyan GuoPageof 216